See also this year's filing and all EDGAR filings for this company.
PDF Report 0001593184_2024_Bioregenx_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'ComprehensiveNetIncome', 'value': -23051041, 'size_variable': 'Assets', 'size_value': 508535, 'ratio': 45.3, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001593184')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('stock_price')"} |
Graph
Absolute values for 0001593184, Bioregenx INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | AssetsNonCurrent | 0 |
| 2 | PropertyPlantAndEquipment | 0 |
| 3 | IntangibleAssets | 0 |
| 4 | LeaseAssets | 0 |
| 5 | remainder_Assets | 31,640 |
| 6 | LiabilitiesCurrent | 253,612 |
| 7 | LiabilitiesNonCurrent | 0 |
| 8 | LeaseLiability | 0 |
| 9 | remainder_Liabilities | 0 |
| 10 | CostOfGoodsAndServicesSold | 0 |
| 11 | GeneralAndAdministrativeExpense | 0 |
| 12 | SellingExpense | 0 |
| 13 | ResearchAndDevelopmentExpense | 0 |
| 14 | remainder_Expenses | 131,906 |
| 15 | remainder_Revenues | 22,243 |
| 16 | remainder_NetIncome | -461,508 |
| 17 | remainder_ComprehensiveNetIncome | -20,900 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 31,640 |
| 1 | Liabilities | 253,612 |
| 2 | Expenses | 131,906 |
| 3 | Revenues | 22,243 |
| 4 | StockholdersEquity | -221,972 |
| 5 | NetIncome | -571,171 |
| 6 | ComprehensiveNetIncome | -592,071 |
| 7 | BaseVar | 460,904 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -7.76 |
| 9 | EconomicCapitalRatio | 0.00137 |
Edgar->Model Mapping
Feature Distribution
Change over Time
